T

Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119

Watchlist Manager
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Watchlist
Price: 18.4 CNY -4.66% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Tianjin Ringpu Bio-Technology Co Ltd?
Write Note

Relative Value

The Relative Value of one Tianjin Ringpu Bio-Technology Co Ltd stock under the Base Case scenario is 30.54 CNY. Compared to the current market price of 18.4 CNY, Tianjin Ringpu Bio-Technology Co Ltd is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
30.54 CNY
Undervaluation 40%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
42
Median 3Y
4
Median 5Y
4.2
Industry
2.5
Forward
3
vs History
69
vs Industry
32
Median 3Y
21.7
Median 5Y
23.4
Industry
21.9
Forward
18.1
vs History
82
vs Industry
29
Median 3Y
21.1
Median 5Y
21
Industry
16.5
vs History
85
vs Industry
23
Median 3Y
36
Median 5Y
36.5
Industry
23.6
vs History
71
vs Industry
51
Median 3Y
2
Median 5Y
2.4
Industry
2.1
vs History
71
vs Industry
45
Median 3Y
3.7
Median 5Y
4.1
Industry
2.6
Forward
3
vs History
66
vs Industry
42
Median 3Y
7.6
Median 5Y
8
Industry
5.2
vs History
58
vs Industry
27
Median 3Y
20.3
Median 5Y
22.2
Industry
13.3
Forward
12.9
vs History
58
vs Industry
31
Median 3Y
20.3
Median 5Y
22.2
Industry
16.6
Forward
16.8
vs History
77
vs Industry
32
Median 3Y
19.1
Median 5Y
19.3
Industry
15.6
vs History
85
vs Industry
16
Median 3Y
51.1
Median 5Y
51.8
Industry
19.1
vs History
79
vs Industry
51
Median 3Y
1.9
Median 5Y
2.1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Tianjin Ringpu Bio-Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
8.6B CNY 3.6 20.2 20.7 20.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top